🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

L3Harris Technologies shares see 17% price target boost as analyst reaffirms Buy rating

EditorAhmed Abdulazez Abdulkadir
Published 10/18/2024, 08:56 PM
LHX
-

On Friday, Truist Securities increased its price target on L3Harris Technologies (NYSE:LHX) to $293 from the previous target of $250. The firm continues to recommend a Buy rating for the defense contractor's stock.

The adjustment comes with the anticipation of a strong demand both domestically and internationally, which is expected to allow the management of L3Harris Technologies to slightly raise its outlook for 2024. This outlook is bolstered by a forecasted book-to-bill (B2B) ratio above 1x in the third quarter of 2024.

The analyst predicts that while Integrated Mission Systems (IMS) and Aviation Reconnaissance (AR) margins may decline in the second half of the year compared to the first half due to product mix, there is still potential for upside at AR. This optimism is based on the progress of integration efforts and related savings outpacing initial plans.

Furthermore, the firm is keen on management's commentary regarding revenue growth expectations for 2025. They anticipate top-line growth to likely be in the range of 4-6%, coupled with strong free cash flow (FCF) conversion.

The price target increase reflects confidence in L3Harris Technologies' future performance, considering the company's strategic position and operational execution. The unchanged revenue and earnings per share (EPS) estimates suggest a stable financial outlook for the company as it navigates the current market environment.

In other recent news, L3Harris Technologies has announced several key developments. The company's Board of Directors has approved a quarterly cash dividend of $1.16 per common share. L3Harris has also introduced its new autonomous vehicle system, Diamondback (NASDAQ:FANG), designed for reconnaissance and security operations. This comes alongside an upgrade from Peerperform to Outperform by Wolfe Research, due to strong margin performance and potential for further expansion.

In addition, L3Harris has secured a potentially lucrative contract with the U.S. Navy, worth $587.4 million, for the provision of new tactical jamming pods over the next five years. Despite not securing the High Accuracy Detection and Exploitation System contract from the US Army, Jefferies has reiterated a Buy rating for L3Harris.

In terms of financial developments, L3Harris reported a 9% increase in non-GAAP earnings per share for the second quarter of 2024, along with a substantial backlog of $32 billion. However, Morgan Stanley downgraded L3Harris's stock from Overweight to Equalweight, citing comparative industry analysis and recent financial developments.

InvestingPro Insights

The recent price target increase by Truist Securities aligns well with L3Harris Technologies' strong market position and financial performance. According to InvestingPro data, the company's revenue growth stands at 15.44% over the last twelve months, with a quarterly growth of 12.91% in Q2 2024. This robust growth supports Truist's optimistic outlook on the company's future performance.

InvestingPro Tips highlight that L3Harris has raised its dividend for 23 consecutive years and has maintained dividend payments for 54 consecutive years. This consistent dividend history underscores the company's financial stability and commitment to shareholder returns, which may be attractive to investors seeking reliable income streams in the defense sector.

Moreover, the company's PEG ratio of 0.81 suggests that it may be undervalued relative to its growth prospects, potentially supporting Truist's bullish stance. With a market capitalization of $47.1 billion and trading near its 52-week high, L3Harris appears to be in a strong position within the Aerospace & Defense industry.

For investors seeking a more comprehensive analysis, InvestingPro offers 11 additional tips for L3Harris Technologies, providing deeper insights into the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.